GETINGE Revenue 2016-2024 | GNGBY

GETINGE revenue from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
GETINGE Annual Revenue
(Millions of US $)
2024 $3,288
2023 $3,001
2022 $2,804
2021 $3,154
2020 $3,250
2019 $2,810
2018 $2,782
2017 $2,639
2016 $3,478
2015 $3,586
GETINGE Quarterly Revenue
(Millions of US $)
2024-09-30 $756
2024-06-30 $797
2024-03-31 $722
2023-12-31 $933
2023-09-30 $704
2023-06-30 $682
2023-03-31 $683
2022-12-31 $805
2022-09-30 $659
2022-06-30 $678
2022-03-31 $662
2021-12-31 $906
2021-09-30 $730
2021-06-30 $783
2021-03-31 $735
2020-12-31 $1,005
2020-09-30 $900
2020-06-30 $721
2020-03-31 $625
2019-12-31 $888
2019-09-30 $651
2019-06-30 $665
2019-03-31 $605
2018-12-31 $884
2018-09-30 $635
2018-06-30 $662
2018-03-31 $601
2017-12-31 $245
2017-09-30 $824
2017-06-30 $823
2017-03-31 $747
2016-12-31 $1,066
2016-09-30 $813
2016-06-30 $844
2016-03-31 $755
2015-12-31 $1,107
Sector Industry Market Cap Revenue
Medical Medical Services $0.000B $3.288B
Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.685B 28.04
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Charles River Laboratories (CRL) United States $8.502B 16.43
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00